Natural Alternatives International (NASDAQ:NAII) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Natural Alternatives International (NASDAQ:NAII) in a research report issued to clients and investors on Tuesday. The firm set a “buy” rating on the stock.

Natural Alternatives International Trading Up 2.4 %

Natural Alternatives International stock opened at $4.31 on Tuesday. The company has a market capitalization of $26.72 million, a price-to-earnings ratio of -2.99 and a beta of 0.58. The company has a current ratio of 2.56, a quick ratio of 1.50 and a debt-to-equity ratio of 0.11. Natural Alternatives International has a 12 month low of $4.11 and a 12 month high of $7.37. The business’s fifty day simple moving average is $4.96 and its two-hundred day simple moving average is $5.65.

Natural Alternatives International (NASDAQ:NAII) last posted its earnings results on Friday, September 27th. The company reported ($0.32) EPS for the quarter. The business had revenue of $29.49 million during the quarter. Natural Alternatives International had a negative return on equity of 10.23% and a negative net margin of 7.53%.

Institutional Trading of Natural Alternatives International

A hedge fund recently raised its stake in Natural Alternatives International stock. Geode Capital Management LLC boosted its holdings in Natural Alternatives International, Inc. (NASDAQ:NAII) by 6.9% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 45,062 shares of the company’s stock after buying an additional 2,915 shares during the period. Geode Capital Management LLC owned 0.73% of Natural Alternatives International worth $258,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 32.40% of the company’s stock.

About Natural Alternatives International

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.